Cutting-Edge Technology Leads to Ground-Breaking Products.

As a product-based company, eXagen™ uses a variety of approaches to develop diagnostic and prognostic tests for use in clinical laboratories:
 

• Coperna™: Our proprietary computational technology gives us the ability to analyze billions of possible combinations of genes to discover those combinations that are most meaningful for disease-specific diagnosis, prognosis or treatment response.

• eXagen is not limited to delivering tests within a particular disease category or test platform. Rather, eXagen's delivery system allows for its assays to be brought to market on the most convenient and effective testing platform appropriate for the assay.

• Pharmaceutical R&D and Clinical Trials: eXagen can assist pharmaceutical companies by identifying small combinations of genomic markers to identify patients who are most likely to respond to the study drug being tested. This will assist pharmaceutical companies with developing more targeted, personalized therapeutics.